---
title: "BioMarin Pharma (BMRN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BMRN.US/norm.md"
symbol: "BMRN.US"
name: "BioMarin Pharma"
parent: "https://longbridge.com/en/quote/BMRN.US.md"
datetime: "2026-05-20T00:14:27.042Z"
locales:
  - [en](https://longbridge.com/en/quote/BMRN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BMRN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BMRN.US/norm.md)
---

# BioMarin Pharma (BMRN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.5431 | -0.2423 | -0.1601 | 1.23 | 0.9544 |
| ROE | 6.86% | -3.07% | -2.04% | 16.28% | 12.97% |
| Revenue | 766.21M | 874.57M | 776.13M | 825.41M | 745.14M |
| Net income | 105.53M | -46.57M | -30.74M | 240.53M | 185.69M |
| Operating income | 137.95M | 196.64M | -46.69M | 276.89M | 223.89M |
| Gross margin | 51.21% | 60.10% | 29.19% | 62.27% | 58.36% |
| Net margin | 13.77% | -5.33% | -3.96% | 29.14% | 24.92% |
| Profit quality | 62.52% | 197.35% | -12.66% | 149.45% | 128.38% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 8.59B | 7.59B | 7.61B | 7.46B | 7.15B |
| Leverage | 1.38 | 1.25 | 1.26 | 1.24 | 1.23 |
| BVPS | 32.14 | 31.65 | 31.53 | 31.39 | 30.21 |
| Turnover | 0.4120 | 0.4418 | 0.4278 | 0.4219 | 0.4209 |
| Cash & STI | 2.22B | 1.56B | 1.48B | 1.43B | 1.27B |
| Inv & Rec | 1.27B | 1.30B | 1.38B | 1.34B | 1.27B |
| LT assets | 958.07M | 991.80M | 1.04B | 1.03B | 1.03B |
| Net debt | -782.83M | -917.74M | -873.60M | -828.26M | -670.38M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 220.65M | 99.64M | 368.69M | 185.27M | 174.39M |
| Investing CF | 725.53M | -42.45M | -330.96M | -12.59M | -28.24M |
| Financing CF | 813.17M | 3.16M | -2.17M | -4.60M | -38.78M |
| Free CF | 168.90M | 90.47M | 115.64M | 98.78M | 104.58M |
| OCF coverage | 1054.59% | 244.69% | 1296.04% | 1083.39% | 1040.04% |
| Repaid & issued | 850.00M | - | - | - | - |
| CapEx | -20.92M | -40.72M | -28.45M | -17.10M | -16.77M |